Sara Penchev

430 total citations
6 papers, 13 citations indexed

About

Sara Penchev is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sara Penchev has authored 6 papers receiving a total of 13 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sara Penchev's work include Glioma Diagnosis and Treatment (5 papers), Radiation Therapy and Dosimetry (3 papers) and Boron Compounds in Chemistry (2 papers). Sara Penchev is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Radiation Therapy and Dosimetry (3 papers) and Boron Compounds in Chemistry (2 papers). Sara Penchev collaborates with scholars based in United States. Sara Penchev's co-authors include James E. Herndon, Ivan Spasojević, Katherine B. Peters, James D. Crapo, Shayne C. Gad, Patrick Healy, Ines Batinić‐Haberle, Annick Desjardins, Rebecca E. Oberley‐Deegan and Shahzad Raza and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Neuro-Oncology.

In The Last Decade

Sara Penchev

6 papers receiving 13 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Penchev United States	3	8	5	4	2	2	6	13
Sonja I. Berndt United States	2	9 1.1×	5 1.0×	3 0.8×		3 1.5×	2	22
E. Suzanna Indonesia	2	6 0.8×	6 1.2×	4 1.0×		1 0.5×	6	15
Laxmi Kumari India	3	7 0.9×	4 0.8×	5 1.3×		2 1.0×	8	13
Diane Heditsian United States	3	7 0.9×	7 1.4×	8 2.0×		2 1.0×	11	20
Stefano Minardi Italy	2	7 0.9×	5 1.0×	3 0.8×		3 1.5×	4	9
Dor Simkin Israel	2	6 0.8×	7 1.4×	3 0.8×		2 1.0×	3	12
Olga Boix Spain	3	11 1.4×	4 0.8×	3 0.8×		3 1.5×	4	16
Teh-Wei Wang Japan	2	7 0.9×	3 0.6×	4 1.0×	1 0.5×		2	21
Patrick J. O’Hearn United States	2	13 1.6×	5 1.0×	6 1.5×		2 1.0×	2	18
Alexandra Berninger Germany	3	9 1.1×	5 1.0×	3 0.8×		1 0.5×	4	15

Countries citing papers authored by Sara Penchev

Since Specialization

Citations

This map shows the geographic impact of Sara Penchev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Penchev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Penchev more than expected).

Fields of papers citing papers by Sara Penchev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Penchev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Penchev. The network helps show where Sara Penchev may publish in the future.

Co-authorship network of co-authors of Sara Penchev

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Penchev. A scholar is included among the top collaborators of Sara Penchev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Penchev. Sara Penchev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Peters, Katherine B., John P. Kirkpatrick, Ines Batinić‐Haberle, et al.. (2022). SPCR-03 NEUROCOGNITIVE OUTCOMES FROM PHASE 1 TRIAL OF BMX-001 IN COMBINATION WITH CONCURRENT RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA PATIENTS. Neuro-Oncology Advances. 4(Supplement_1). i20–i20. 1 indexed citations

Lin, Chi, Jean L. Grem, Kelsey Klute, et al.. (2021). The Phase I Results of a Phase 1/2 Trial for Patients With Newly Diagnosed Anal Cancer Treated With Concurrent Radiation Therapy, 5-Fluorouracil, Mitomycin and BMX-001. International Journal of Radiation Oncology*Biology*Physics. 111(3). S103–S103. 1 indexed citations

Peters, Katherine B., John L. Villano, Nicholas Butowski, et al.. (2021). Phase 2 trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.. Journal of Clinical Oncology. 39(15_suppl). TPS2069–TPS2069. 1 indexed citations

Peters, Katherine B., Adam L. Cohen, Nicholas Butowski, et al.. (2020). BMX-HGG: Phase II trial of newly diagnosed high-grade glioma treated with concurrent radiation therapy, temozolomide, and BMX-001.. Journal of Clinical Oncology. 38(15_suppl). TPS2577–TPS2577. 2 indexed citations

Peters, Katherine B., John P. Kirkpatrick, Mary Lou Affronti, et al.. (2019). First in Human Clinical Trial of a Metalloporphyrin Dual Radioprotectant and Radiosensitizer, BMX-001, in Newly Diagnosed High-Grade Glioma Undergoing Concurrent Chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 105(1). E106–E106. 5 indexed citations

Peters, Katherine B., John P. Kirkpatrick, Ines Batinić‐Haberle, et al.. (2018). ACTR-28. PHASE 1 DOSE ESCALATION TRIAL OF THE SAFETY OF BMX-001 CONCURRENT WITH RADIATION THERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED PATIENTS WITH HIGH-GRADE GLIOMAS. Neuro-Oncology. 20(suppl_6). vi17–vi17. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact